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DObjective: To determine the feasibility of original aortic valve reconstruction, 404 consecutive cases were re-
viewed. The early results are reported here.
Methods:Aortic valve reconstruction was performed for 404 patients fromApril 2007 through September 2011.
The results for all 404 patients were reviewed retrospectively. There were 289 patients with aortic stenosis and
115 patients with aortic regurgitation. One hundred two patients had bicuspid aortic valves, 13 patients had uni-
cuspid valves, and 2 patients had quadricuspid valves. There were 201 males and 203 females. Mean age was
69.0  12.9 years. Preoperative echocardiography revealed an average peak pressure gradient of 79.6  32.5
mm Hg with aortic stenosis. Surgical annular diameter was 20.3  3.2 mm. The surgical procedure is based
on the independent tricuspid replacement by autologous pericardium. First, the distance between the commis-
sure is measured with an original sizing apparatus, then the pericardial cusp is trimmed using an original tem-
plate, and it is sutured to the annulus.
Results: There were no conversions to prosthetic valve replacement. There were 7 in-hospital mortalities result-
ing from a noncardiac cause. Postoperative echocardiography revealed an average peak pressure gradient of
19.8  10.2 mm Hg 1 week after surgery and 13.8  3.7 mm Hg 3.5 years after surgery. Two patients needed
reoperation because of infective endocarditis. The other 402 patients showed less than mild aortic regurgitation.
No thromboembolic events were recorded. The mean follow-up period was 23.7  13.1 months. Freedom from
reoperation was 96.2% at 53 months of follow-up.
Conclusions: Original aortic valve reconstruction was feasible in patients with various aortic valve diseases.
Long-term data will be disclosed in the future. (J Thorac Cardiovasc Surg 2014;147:301-6)Atrioventricular valve repair has become more popular than
valve replacement with its standardization and reproducibil-
ity. For aortic valve disease, bioprosthetic valves are being
used increasingly for replacement because of the problems
with anticoagulation ofmechanical valves. However, despite
the progress of the design and construction of prosthetic
valves, hemodynamic performance is not yet comparable
with that of native aortic valves.1 In recent years,much atten-
tion has been given to repairing aortic valve disease, with
consequent improvement in postoperative results.
Many reports of aortic valve repair are limited to the
treatment for aortic regurgitation (AR).2,3 Our new style
of aortic valve reconstruction can be applied to a wide
spectrum of aortic valve diseases, including aortic
stenosis (AS), AR, infective endocarditis (IE), prosthetic
valve endocarditis (PVE), and annulo-aortic ectasia.e Department of Cardiovascular Surgery, Toho University Ohashi Medical
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The Journal of Thoracic and CaWe basically replace all 3 aortic valve cusps by
glutaraldehyde-treated autologous pericardium. We as-
sume this technique is more like valve reconstruction
than replacement because there is no use of foreign mate-
rial and no need for postoperative anticoagulation. The
main reason why we call this technique a reconstruction
is that we can make new cusps, one by one, from the dis-
tance between each commissure in the operative field.
There have been some reports of aortic valve reconstruc-
tion with autologous pericardium or stentless autologous
pericardial aortic valve replacement.4,5 These reports
mentioned the advantage of direct suturing of the
pericardium to the annulus.6-9 With this method,
surgeons can preserve the natural aortic root expansion
in the systole with maximal effective orifice area,10-12
but they still replace the aortic valve as 1 whole
structure. The difference in our original aortic valve
reconstruction from others is the independent
replacement of 3 cusps by 3 native-size autologous peri-
cardial cusps. We consider the size of the aortic cusp to
be defined by the distance between the commissures. In
addition, aortic valves may represent a collection of
different-size cusps. We believe independent replacement
of cusps is more effective in preserving the natural motion
of the aortic valve annulus and the coordination of the left
ventricle, aortic annulus, sinus of Valsalva, and aorta.rdiovascular Surgery c Volume 147, Number 1 301
Abbreviations and Acronyms
AR ¼ aortic regurgitation
AS ¼ aortic stenosis
IE ¼ infective endocarditis
PVE ¼ prosthetic valve endocarditis
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DTo inspect the feasibility of original aortic valve recon-
struction, 404 consecutive patient results were reviewed.FIGURE 1. Management of pericardium. Generally speaking, pericar-
dium becomes thicker as it approaches the diaphragm. On the other
hand, it becomes thinner as it reaches the aorta. A larger cusp tends to
have the more shear stress, and its opening/closing movement can be
smooth regardless of its stiffness. Therefore, we always make the larger
cusp from the diaphragm side and the smaller cusps from the aortic side.METHODS
Our new original aortic valve reconstruction and the clinical study of
this procedure were approved by the institutional review board of Toho
University Ohashi Medical Center. All patients underwent this operation
after written informed consent was obtained.
Our original aortic valve reconstruction was performed on 404 patients
from April 2007 through September 2011. We reviewed retrospectively all
404 patients and evaluated short-term and mid-term results.
The indication of our original aortic valve reconstruction was first by
echocardiography for the patients with a small aortic annulus with a diam-
eter 21.5 mm, and second for patients who rejected mechanical valve im-
plantation. Among them, we performed this reconstruction for patients who
were willing to have this operation.
There were 201 males and 203 females. Mean age was 69.0  12.9
years. Preoperative echocardiography revealed an average peak pressure
gradient through the aortic valve of 79.6  32.5 mm Hg for patients with
AS and a surgical annular diameter of 20.8  3.2 mm for all patients.
Two hundred eighty-nine patients had AS and 115 patients had AR. One
hundred two patients had bicuspid aortic valves, 13 patients had unicuspid
valves, and 2 patients had quadricuspid valves. Annulo-aortic ectasia was
recorded in 8 patients. The other 13 patients had IE.
Surgical Technique
The surgical technique for our original aortic valve reconstruction has
been reported previously.13 Preparation of autologous pericardium was
started by cleaning fat and other redundant tissue on the outer surface of
pericardium with the Harmonic scalpel (Ethicon Endo-Surgery, Inc, Cin-
cinnati, Ohio). Pericardium was excised at least 7 3 8 cm. The excised
pericardium was then treated with 0.6% glutaraldehyde solution with
a buffer for 10 minutes. The treated pericardium was rinsed 3 times using
physiologic saline solution for 6 minutes.
Human pericardium is usually thin near the cranial end and thick caudally
near the diaphragm. We use the thinner part of pericardium for small cusps to
make themovement smoother, and the thickerpart for large cusps tomake them
able to tolerate more stress (Figure 1). All aortic valve reconstructive proce-
dures were performed during cardioplegic arrest on cardiopulmonary bypass.
Briefly, diseased cusps are excised meticulously. In case there is severe
calcification along the aortic annulus, the Cavitron Ultrasonic Surgical As-
pirator (SonoSurg, Olympus, Tokyo, Japan) is very helpful in removing
calcium without damaging annular tissue. Then, the distance between
each commissure is measured with an originally invented sizing apparatus.
The intercommissural distance is measured using the original sizing appa-
ratus by giving the appropriate tension, similar to reproducing the annulus
during diastole. Correct measurement is vital to complete this operation.
The new cusp with the size corresponding to the measured value is trimmed
with an original template from glutaraldehyde-treated autologous pericar-
dium. Last, the annular margin of the pericardial cusp is sutured with run-
ning 4-0monofilament stitches to each annulus. The smooth (inner) surface
of pericardium is placed on the left ventricular side. A running suture
should be used to produce the natural, 3-dimensional bulge of the cusps ef-
fectively (Figure 2). The pericardial cusp is sewn thoroughly up to the top302 The Journal of Thoracic and Cardiovascular Surgof commissure, and it is designed to have a deep coaptation that reaches up
to the same horizontal plane as the commissure (Figure 3, A). The commis-
sural coaptation is secured with additional 4-0 monofilament sutures. Re-
cently, we added the small wing at the commissural part of pericardial
cusps to get more tolerance to shear stress and even better coaptation
(Figure 3, B and C). The coaptation of 3 new cusps is ensured with a visual
check under negative pressure made by the left ventricular vent before clo-
sure of the aortotomy (Figure 3, D).
Follow-up
All the patients were monitored at the outpatient clinic of our hospital or
at the referral hospital. Echocardiographic evaluation has been done 1
week, 1 month, 3 months, and every 6 months after surgery.
Statistical Analysis
Data are presented as mean standard deviation. Survival rate and free-
dom from reoperation rate were calculated by Kaplan-Meier method.RESULTS
No operation to convert to a prosthetic valve replacement
was required. Aortic valve disease with IE and PVE could
be operated in the same fashion. For AR with annulo-
aortic ectasia, our original aortic valve reconstruction could
be combined effectively with the aortic root reimplantation
technique. Mean aortic crossclamp time was 110.1  26.8
minutes, and mean cardiopulmonary bypass time was
149.4  29.9 minutes for isolated aortic valve reconstruc-
tions. Mean ischemic time was reduced to 96.7 26.9 min-
utes among patients operated from January 2011 through
September 2011. We have never resumed cardiopulmonary
bypass to place additional sutures or to readjust the heights
of the commissure or redundancy of the cusps.
Mean follow-up was 23.7  13.1 months. Survival rate
was 87.7% at 53 months (Figure 4, A). The freedom from
reoperation rate was 96.2 % (Figure 4, B). Reoperations
were recorded for 2 patients, both because of IE. One was
10 months after the first operation and was induced by pace-
maker implantation; the other was for a patient on hemodi-
alysis 3.5 years after the first operation. These twoery c January 2014
FIGURE 2. Suturing technique of the pericardial cusp. The suture is begun
at the center of the annulus. This suture is tied and the ends are continued as
a running suturebidirectionally.The ratio of distancebetween eachbite on the
pericardium and the annulus should be 3:1 at the bottomof the annulus, and it
should be changed to 1:1 when the suture comes up to the coaptation zone.
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Dreoperated patients were the only valve-related complica-
tions in this series. There were 7 in-hospital deaths with
a noncardiac cause. The cause of in-hospital deaths in-
cluded 3 cases of pneumonia, 2 cases of thrombotic throm-
bocytopenic purpura, 1 tracheal perforation, and 1 acute
mesenteric ischemia. Twenty mortalities were recorded
during the follow-up period after discharge from the hospi-
tal. No embolic event was recorded while patients received
a small dose of daily aspirin. Basically, we do not provide
anticoagulation postoperatively. Anticoagulation was used
for 100 patients because of the concomitant procedure in-
cluding coronary artery bypass surgery, mitral valve repair,
and tricuspid valve repair.
Preoperative average peak pressure gradient through the
aortic valve with echocardiography was 73.5  38.2 mm
Hg. The pressure gradient decreased 19.8  3.7 mm Hg 1
week after surgery and 13.8 3.7 mmHg 3.5 years after sur-
gery (Figure 5, A). The degree of aortic regurgitation with
echocardiography was less than mild postoperatively
(Figure 5, B).
DISCUSSION
Aortic valve repair became feasible with low mortality in
many patients with aortic regurgitation. It is showing better
results in terms of freedom from valve-related complications
compared with conventional aortic valve replacement.14 The
important milestones in the development of aortic valve re-
pair have already been achieved as it evolves into a viableThe Journal of Thoracic and Caalternative to aortic valve replacement in patients with aortic
regurgitation.15 The origin of aortic valve repair can be
traced back to the early era of cardiac surgery.16 Aortic valve
repair has been performed using native valve cusps by vari-
ous techniques that include commissurotomy,17 annulo-
plasty, free edge unrolling, cusp resuspension, supra-aortic
crest enhancement, free edge reinforcement, wedge resec-
tion, and so on.18 This type of conservative repair is not al-
ways possible, especially for calcified AS in aging elderly
patients. Simple decalcification or slicing of cusps has not
shown good results. On the other hand, there is an apparent
limitation of durability with bioprosthetic valves and an ap-
parent disadvantage of anticoagulation with mechanical
prostheses. Moreover, both prostheses cannot create good
hemodynamics compared with a native aortic valve.
Attempts to replace aortic valve cusp tissue with biologic
material have been made since the late 1960s.19-21 Fascia
lata, dura mater, and bovine pericardium have been used
in a small number of patients, but the results have not
been favorable in the majority of instances. Halees and
colleagues4 reported that autologous pericardium and bo-
vine pericardium did not show a difference in terms of struc-
tural valve deterioration with 16 years of follow-up of aortic
valve reconstruction. But, they found more cases of late cal-
cification with bovine pericardium than with autologous
pericardium.4 Autologous pericardium is easily available
for immediate aortic valve repair in every patient.
Aortic valve repair using autologous pericardial cusp exten-
sionhasbeendescribedbyDuran andassociates.9,18,22,23They
treated autologous pericardium with glutaraldehyde solution.
The treated pericardium was used to increase the height of
native aortic valve cusps and commissures, resulting in an
increase of the coaptation zone. Glutaraldehyde treatment
can provide more resistance against retraction and
degeneration, and maintains intrinsic tissue pliability to the
pericardium. We also used 0.6% glutaraldehyde solution
with buffer to treat pericardium. The ultimate tensile
strength of glutaraldehyde-treated human pericardium was 4
times greater than noncalcified leaflets, indicating its suitabil-
ity for application to aortic valve reconstruction.24
Halees and colleagues4 reported an overall reoperation-
free survival of 47% at 16 years after aortic valve recon-
struction with pericardium. It is their contention that cusp
extension or replacement of the 3 aortic cusps with a single
strip of pericardium is technically more reliable. Odim and
coworkers25 reported that aortic valve repair with autolo-
gous pericardial cusp extension was a good alternative for
a congenitally diseased aortic valve. Chan and colleauges5
reported 11 patients of truly stentless autologous pericardial
aortic valve replacement. With their 6.5 years of follow-up,
freedom from structural valve deterioration was 100%. One
patient was reoperated 15 months after surgery, and the re-
placed autologous pericardium showed no calcification and
had well-preserved collagen fibers.rdiovascular Surgery c Volume 147, Number 1 303
FIGURE 3. A, Concept of commissure height. An original template was designed to make pericardial leaflets have deep coaptation up to the same hor-
izontal plane as the top of the commissures. B, Commissure creation. With the commissural wing sewed facing the aortic wall, the commissural part of each
cusp can have more strength to tolerate the maximal stress, and the commissural part of each cusp bulges naturally toward the aortic lumen, which gives
better coaptation for the cusps. C, upper left, The first annular suture is pulled out around the center of wing along the annular suture marking line to just
inside (below) the native commissure. Second commissuroplasty suture (4-0 prolene RB-1) is first passed through both sides of cusps just above the last bite
of annular stitch along the annular suture marking line. Then, the second commissuroplasty suture is passed throughmore laterally and upward near the edge
of wing, and through the aortic wall above the commissure to fit this wing against the aortic wall.Upper right, Annular stitches travel more narrow and lower
(inside the commissure), and commissuroplasty stitches travel wider and higher (outside the commissure). This is same on the felt pledget. Lower, Thewings
should fit nicely to the aortic wall above the annular line. D, Real completion of aortic valve reconstruction including commissuroplasty.
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DOur original aortic valve reconstruction technique does
not focus on total repair with a single strip of pericardium.
On the contrary, we make much of the way of thinking that
the aortic valve represents a collection of different-size
cusps, so we consider the size of the aortic cusp to be de-
fined independently by the distance between the commis-
sure. As a result, we create pericardial cusps separately
for each coronary cusp, and each cusp may be a different
size from the other. Based on our collected data, aortic
valves represent a collection of different-size cusps.
Among tricuspid patients, 13% showed 3 equidistant
measurements between commissures. Fifty-seven percent304 The Journal of Thoracic and Cardiovascular Surgof patients had 2 equidistant measurements, and the remain-
ing 30% had 3 different distances.
With native aortic valves, the cusp contacting point is
slightly lower compared with the horizontal plane made
by the top of the commissures (Figure 3, A). Its level is
different in each case. If the cusp contact point is far be-
low the commissural level, the cusp free-edge length is
made longer. If the cusp contact point is near the commis-
sural level, the cusp free-edge length is made shorter. We
thought it difficult to calculate the cusp free-edge length
from the annular diameter in consideration of these
factors.ery c January 2014
FIGURE 4. A, Survival curve with 95% confidence limits. B, Freedom
from reoperation curve with 95% confidence limits.
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DThere are 2 essential features of our original reconstruc-
tion that is completely different from others. First, we cal-
culate cusp free-edge length from the intercommissural
length and second, the contact point of the new pericardial
cusps is raised up to the same plane of the commissures.
From these two concepts, we have realized two advantages.
First, we are able to have a larger coaptation zone and, sec-
ond, we can determine the cusp free-edge length from the
distance between the commissure on the same 2-dimen-
sional plane as one-to-one correspondence. Therefore, it be-
comes easy to recognize the area of each cusp (Figure 3,D).
Our concept is based on the premise that the length of each
cusp free edge is in proportion to the distance between eachFIGURE 5. Left, Follow-up echocardiographic evaluation of peak pressure gra
evaluation of aortic regurgitation after aortic valve reconstruction.
The Journal of Thoracic and Cacommissure. This value is sufficient to determine the new
size of cusps, rather than fully calculating each cusp area.
With our template, the size of the new pericardial cusp is de-
termined by 3 factors: the length of the cusp free edge, the
larger coaptation zone, and the margin for seams. Correct
measurement of the distance between each commissure
and a suturing technique with a ratio of 3:1 at the bottom
and 1:1 the near commissures to produce cusps that have
a nice round bulge are the keys to this procedure. If these
2 factors are done well, reconstruction should be successful.
In fact, we have never resumed cardiopulmonary bypass to
place additional sutures or to readjust the heights of the
commissure or redundancy of the cusps.
We believe independent replacement of cusps is more ef-
fective in preserving the natural motion of the aortic valve
annulus and the coordination of the left ventricle, aortic
annulus, sinus of Valsalva, and aorta. With our technique
of total resection of all 3 diseased cusps, our procedure
can be applied to any type of aortic valve disease. In fact,
we can operate on patients with AS, AR, IE, and PVE, and
thosewith bicuspid, unicuspid,26 and quadricuspid27 valves,
basically in the same fashion. Even for annulo-aortic ectasia,
this technique can be applied with root reimplantation. This
wide applicability can be attributed also to the independent
reconstruction of 3 cusps. In a situation with an intact aortic
annulus, this new reconstruction technique can be applied to
all kinds of aortic valve diseases. To secure the intact aortic
annulus, the Cavitron Ultrasonic Surgical Aspirator is used
to remove calcium without damaging annular tissue.Study Limitations
The limitations of this study relate to its retrospective
nature and the limited follow-up. Moreover, this study
was not a case–control study. A prospective case–control
study would be ideal to determine the efficacy of our new
aortic valve reconstruction compared with other conven-
tional aortic valve replacement or repair procedures.
Long-term results have to be studied with a follow-up of
15 to 20 years.
Although our cardiopulmonary bypass time and aortic
crossclamp timewere longer than seen in standard aortic valvedient after aortic valve reconstruction. Right, Follow-up echocardiographic
rdiovascular Surgery c Volume 147, Number 1 305
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of life, with good hemodynamics and a warfarin-free condi-
tion. And, with good hemodynamics and a natural, smooth
motion of pericardial cusps, we can expect better longevity
compared with previously reported techniques or materials.CONCLUSIONS
Our original aortic valve reconstruction provides good
short- and mid-term results along with good hemodynamics
and a good quality of life without anticoagulation. This pro-
cedure is effective for a wide variety of aortic valve
diseases. Assessment of long-term data, especially concern-
ing valve durability, will be disclosed in the future.
We thank Prof Hartzell V. Schaff for giving us suggestions to
complete this manuscript.References
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